Banking of fresh-frozen prostate tissue: methods, validation and use

被引:36
作者
Riddick, ACP
Barker, C
Sheriffs, I
Bass, R
Ellis, V
Sethia, KK
Edwards, DR
Ball, RY
机构
[1] Norfolk & Norwich Univ Hosp, Dept Histopathol, Norwich NR4 7UY, Norfolk, England
[2] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England
关键词
prostate; tissue bank; quality assurance; mRNA; quantitative RT-PCR; hepsin;
D O I
10.1046/j.1464-410X.2003.03041.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To describe the establishment, methods, validation and use of a bank of fresh-frozen human prostate tissue. MATERIALS AND METHODS On obtaining informed patient consent, protocols were followed for banking prostate tissue from any type of prostatectomy or cystoprostatectomy. A pseudobanking procedure was devised to determine the accuracy of assessing the histopathological status of the banked tissue. RNA was extracted, its quality assessed and used for quantitative real-time reverse transcription-polymerase chain reaction for the serine protease hepsin. RESULTS To date prostate tissue from 112 patients has been banked, with pseudobanking in 58. The histopathological assessment showed pseudobanked tissue matched adjacent unbanked tissue in 98% of cases for benign vs malignant diagnoses, and in 92% of carcinomas for the Gleason score. Hepsin expression was significantly higher in malignant than in benign tissues (P < 0.0001). CONCLUSION We established a validated method for banking human fresh-frozen prostate tissue and applied it successfully. Hepsin expression can be used to differentiate malignant and benign prostate tissue, and as an indicator of tissue heterogeneity.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 19 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[2]   The establishment of human research tissue banking in the UK and several western European countries - The report and recommendations of ECVAM Workshop 44 [J].
Anderson, R ;
Balls, M ;
Burke, MD ;
Cummins, M ;
Fehily, D ;
Gray, N ;
de Groot, MG ;
Helin, H ;
Hunt, C ;
Jones, D ;
Price, D ;
Richert, L ;
Ravid, R ;
Shute, D ;
Sladowski, D ;
Stone, H ;
Thasler, W ;
Trafford, J ;
van der Valk, J ;
Weiss, T ;
Womack, C ;
Ylikomi, T .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2001, 29 (02) :125-134
[3]   The role of the pathologist as tissue refiner and data miner: The impact of functional genomics on the modern pathology laboratory and the critical roles of pathology informatics and bioinformatics [J].
Becich, MJ .
MOLECULAR DIAGNOSIS, 2000, 5 (04) :287-299
[4]  
Best C J, 2001, Expert Rev Mol Diagn, V1, P53, DOI 10.1586/14737159.1.1.53
[5]  
Burke HB, 1998, ARCH PATHOL LAB MED, V122, P871
[6]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[7]   Molecular profiling of clinical tissue specimens -: Feasibility and applications [J].
Emmert-Buck, MR ;
Strausberg, RL ;
Krizman, DB ;
Bonaldo, MF ;
Bonner, RF ;
Bostwick, DG ;
Brown, MR ;
Buetow, KH ;
Chuaqui, RF ;
Cole, DA ;
Duray, PH ;
Englert, CR ;
Gillespie, JW ;
Greenhut, S ;
Grouse, L ;
Hillier, LW ;
Katz, KS ;
Klausner, RD ;
Kuznetzov, V ;
Lash, AE ;
Lennon, G ;
Linehan, WM ;
Liotta, LA ;
Marra, MA ;
Munson, PJ ;
Ornstein, DK ;
Prabhu, VV ;
Prange, C ;
Schuler, GD ;
Soares, MB ;
Tolstoshev, CM ;
Vocke, CD ;
Waterston, RH .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1109-1115
[8]  
Grizzle WE, 1998, ARCH PATHOL LAB MED, V122, P1065
[9]   The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M - A time-course study using real-time quantitative reverse transcription-polymerase chain reaction [J].
Koshy, PJT ;
Lundy, CJ ;
Rowan, AD ;
Porter, S ;
Edwards, DR ;
Hogan, A ;
Clark, IM ;
Cawston, TE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :961-967
[10]  
Luo J, 2001, CANCER RES, V61, P4683